SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059235
Filing Date
2018-11-13
Accepted
2018-11-13 13:32:06
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506413_10q.htm 10-Q 444532
2 EXHIBIT 31.1 tv506413_ex31-1.htm EX-31.1 9648
3 EXHIBIT 31.2 tv506413_ex31-2.htm EX-31.2 9571
4 EXHIBIT 32.1 tv506413_ex32-1.htm EX-32.1 5023
5 EXHIBIT 99.1 tv506413_ex99-1.htm EX-99.1 62976
6 GRAPHIC image_001.jpg GRAPHIC 27890
  Complete submission text file 0001144204-18-059235.txt   4338505

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fencf-20180930.xml EX-101.INS 1366012
8 XBRL TAXONOMY EXTENSION SCHEMA fencf-20180930.xsd EX-101.SCH 31555
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20180930_cal.xml EX-101.CAL 17284
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20180930_def.xml EX-101.DEF 174154
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20180930_lab.xml EX-101.LAB 200561
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20180930_pre.xml EX-101.PRE 195561
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 181176952
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1